Politics around the globe

Supreme Court Turns Away Biogen Bid to Reinstate MS Drug Patent

Published on Ottobre 3, 2022

The U.S. Supreme Court on Monday declined to hear Biogen Inc’s bid to win reinstatement of a patent on the company’s blockbuster multiple sclerosis drug Tecfidera in a dispute with Viatris Inc subsidiary Mylan Pharmaceuticals Inc

You may also be interested in

Sen. Fetterman: Trump Forged Special Bond in Pa. After Shooting

Settembre 20, 2024

Sen. John Fetterman, D-Pa., said Thursday that former President Donald Trump has created a special bond with Pennsylvanians following the assassination attempt against him July

Border Chief Warned Not to Disclose Arrests of Migrants With Terror Ties

Settembre 20, 2024

A retired Border Patrol agent told lawmakers Wednesday that the Biden administration directed him not to disclose arrests of illegal border crossers classified as “Significant